Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1964 1
1965 1
1969 1
1989 1
1990 1
2002 1
2004 1
2005 1
2006 1
2008 1
2009 2
2010 6
2011 2
2013 6
2014 6
2015 8
2016 7
2017 5
2018 5
2019 3
2020 4
2021 10
2022 9
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.
Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H, San JE, Cromer D, Scheepers C, Amoako DG, Karim F, Bernstein M, Lustig G, Archary D, Smith M, Ganga Y, Jule Z, Reedoy K, Hwa SH, Giandhari J, Blackburn JM, Gosnell BI, Abdool Karim SS, Hanekom W; NGS-SA; COMMIT-KZN Team; von Gottberg A, Bhiman JN, Lessells RJ, Moosa MS, Davenport MP, de Oliveira T, Moore PL, Sigal A. Cele S, et al. Among authors: cromer d. Nature. 2022 Feb;602(7898):654-656. doi: 10.1038/s41586-021-04387-1. Epub 2021 Dec 23. Nature. 2022. PMID: 35016196 Free PMC article.
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection.
Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H, San JE, Cromer D, Scheepers C, Amoako D, Karim F, Bernstein M, Lustig G, Archary D, Smith M, Ganga Y, Jule Z, Reedoy K, Hwa SH, Giandhari J, Blackburn JM, Gosnell BI, Abdool Karim SS, Hanekom W; NGS-SA; COMMIT-KZN Team; von Gottberg A, Bhiman J, Lessells RJ, Moosa MS, Davenport MP, de Oliveira T, Moore PL, Sigal A. Cele S, et al. Among authors: cromer d. medRxiv. 2021 Dec 17:2021.12.08.21267417. doi: 10.1101/2021.12.08.21267417. Preprint. medRxiv. 2021. PMID: 34909788 Free PMC article. Updated.
Within-host modeling of blood-stage malaria.
Khoury DS, Aogo R, Randriafanomezantsoa-Radohery G, McCaw JM, Simpson JA, McCarthy JS, Haque A, Cromer D, Davenport MP. Khoury DS, et al. Among authors: cromer d. Immunol Rev. 2018 Sep;285(1):168-193. doi: 10.1111/imr.12697. Immunol Rev. 2018. PMID: 30129195 Review.
Population heterogeneity in Plasmodium vivax relapse risk.
Stadler E, Cromer D, Mehra S, Adekunle AI, Flegg JA, Anstey NM, Watson JA, Chu CS, Mueller I, Robinson LJ, Schlub TE, Davenport MP, Khoury DS. Stadler E, et al. Among authors: cromer d. PLoS Negl Trop Dis. 2022 Dec 19;16(12):e0010990. doi: 10.1371/journal.pntd.0010990. eCollection 2022 Dec. PLoS Negl Trop Dis. 2022. PMID: 36534705 Free PMC article. Clinical Trial.
Functional cure of HIV: the scale of the challenge.
Davenport MP, Khoury DS, Cromer D, Lewin SR, Kelleher AD, Kent SJ. Davenport MP, et al. Among authors: cromer d. Nat Rev Immunol. 2019 Jan;19(1):45-54. doi: 10.1038/s41577-018-0085-4. Nat Rev Immunol. 2019. PMID: 30410126 Review.
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models.
Khoury DS, Wheatley AK, Ramuta MD, Reynaldi A, Cromer D, Subbarao K, O'Connor DH, Kent SJ, Davenport MP. Khoury DS, et al. Among authors: cromer d. Nat Rev Immunol. 2020 Dec;20(12):727-738. doi: 10.1038/s41577-020-00471-1. Epub 2020 Nov 2. Nat Rev Immunol. 2020. PMID: 33139888 Free PMC article. Review.
81 results